What is AMG 404? A Look at a Novel Anti-PD-1 Immunotherapy
•
3 min read
According to clinical trial data, the investigational immune checkpoint inhibitor AMG 404 demonstrated encouraging antitumour activity across various advanced solid tumour types, particularly in MSI-H cohorts. So, what is AMG 404, and how does this monoclonal antibody work to fight cancer?
